•
Shanghai-based biotechnology company Revvity has entered into a comprehensive partnership with Sanyou Biopharmaceuticals Co., Ltd to enhance the development of innovative biologic drugs. The two companies have signed a commercial licensing agreement that will see Sanyou incorporate the TnT transposon system into the CHOSOURCE protein expression platform. Financial details of…